| Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial (NCT02646449) | University of Pittsburgh | 2015-06-01 |
| A Study of Intermittent Doses of CERC-301 in MDD (NCT02459236) | Avalo Therapeutics, Inc. | 2015-06-01 |
| Gait, Depression, and Mind-body Therapy in Seniors (NCT02283541) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-06-01 |
| Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness (NCT02421965) | Dartmouth-Hitchcock Medical Center | 2015-06-01 |
| Transcranial Alternating Current Stimulation for Major Depressive Disorder (NCT02339285) | University of North Carolina, Chapel Hill | 2015-05-07 |
| A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder (NCT02436239) | Forest Laboratories | 2015-05-02 |
| Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists (NCT02423824) | University Health Network, Toronto | 2015-05-01 |
| Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR) (NCT02711215) | Medical University of Vienna | 2015-05-01 |
| Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder (NCT03554447) | Mahmoud Samy Abdallah | 2015-04-20 |
| miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome (NCT02418195) | University of Alabama at Birmingham | 2015-04-20 |
| Vagus Nerve Stimulation: Integration of Behavior and Cardiac Modulation (NCT04467164) | Massachusetts General Hospital | 2015-04-15 |
| A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder (NCT02389816) | Takeda | 2015-04-10 |
| A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder (NCT02395978) | BioLite, Inc. | 2015-04-10 |
| Connectivity Affecting the Antidepressant REsponse Study (NCT02332291) | Vanderbilt University Medical Center | 2015-04-01 |
| 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females (NCT02356107) | Perry Renshaw | 2015-04-01 |
| Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression (NCT02375308) | University Hospital Tuebingen | 2015-04-01 |
| The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder (NCT02657980) | Ybrain Inc. | 2015-04-01 |
| A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise (NCT02407704) | Kirk Erickson, PhD | 2015-03-01 |
| IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM) (NCT02176226) | Northwestern University | 2015-03-01 |
| Mood Patient Powered Research Network (MoodNetwork) (NCT02453438) | Massachusetts General Hospital | 2015-03-01 |
| Task Sharing for the Care of Severe Mental Disorders in a Low-income Country (NCT02308956) | University of Cape Town | 2015-03-01 |
| Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) (NCT02372799) | Forest Laboratories | 2015-02-28 |
| Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) (NCT02371980) | Takeda | 2015-02-10 |
| Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers (NCT02366364) | Naurex, Inc, an affiliate of Allergan plc | 2015-02-01 |
| e-Compared-S: Comparative Effectiveness Research on Internet-based Depression Treatment - Spanish Trial (NCT02361684) | Universitat Jaume I | 2015-02-01 |
| Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine (NCT02332954) | Lundbeck Canada Inc. | 2015-02-01 |
| Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder (NCT02362529) | Centre for Addiction and Mental Health | 2015-02-01 |
| Clinical Registry of Patients Under Treatment With Atypical Antipsychotics (NCT02409823) | Pontifical Catholic University of Argentina | 2015-02-01 |
| Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis (NCT02443584) | Avera McKennan Hospital & University Health Center | 2015-02-01 |
| Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients (NCT02188121) | Mclean Hospital | 2015-02-01 |
| A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine (NCT03609190) | Psychiatric University Hospital, Zurich | 2015-01-01 |
| An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression (NCT01438242) | Genomind, LLC | 2015-01-01 |
| Memory Flexibility Training for Depression (NCT02371291) | Medical Research Council Cognition and Brain Sciences Unit | 2015-01-01 |
| Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder (NCT02461927) | VA Office of Research and Development | 2015-01-01 |
| Adjunct Minocyline in Treatment-resistant Depression (NCT02456948) | Charite University, Berlin, Germany | 2015-01-01 |
| Family Psychoeducation for Major Depressive Disorder (NCT02348827) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2015-01-01 |
| Partnership in Medication Management (PIMM) in Patients With Mood Disorders (NCT02285608) | St. Joseph's Healthcare Hamilton | 2015-01-01 |
| Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial (NCT03121573) | Taichung Veterans General Hospital | 2014-12-15 |
| Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis (NCT02330679) | University of Calgary | 2014-12-01 |
| Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder (NCT02272517) | H. Lundbeck A/S | 2014-12-01 |
| Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine (NCT02263248) | Centre for Addiction and Mental Health | 2014-12-01 |
| Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder (NCT02294305) | The Medical Research Network | 2014-12-01 |
| Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder (NCT02134808) | Perry Renshaw | 2014-11-21 |
| Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders (NCT01947647) | VA Office of Research and Development | 2014-11-17 |
| Acupuncture in Depression: From the Clinical Trial, Biomarkers to Molecular Biology (NCT03452384) | National Science and Technology Council, Taiwan | 2014-11-06 |
| Mental Health Telemetry for Self-Management in Major Depression (NCT01999010) | Sunnybrook Health Sciences Centre | 2014-11-01 |
| Biomarkers of Social Sensitivity in Major Depression (NCT02214511) | Institut National de la Santé Et de la Recherche Médicale, France | 2014-10-23 |
| rTMS for PTSD Comorbid With Major Depressive Disorder (NCT02273063) | Butler Hospital | 2014-10-01 |
| Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder (NCT02279953) | H. Lundbeck A/S | 2014-10-01 |
| A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A) (NCT02269540) | Centre for Addiction and Mental Health | 2014-10-01 |
| Multicomponent Yoga Intervention for Major Depressive Disorder (NCT02616549) | University of Pennsylvania | 2014-10-01 |
| Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder (NCT02279966) | H. Lundbeck A/S | 2014-10-01 |
| Improving Therapeutic Learning in Depression: Proof of Concept (NCT02376257) | Boston University Charles River Campus | 2014-09-16 |
| Open Label Extension for GLYX13-C-202, NCT01684163 (NCT02192099) | Naurex, Inc, an affiliate of Allergan plc | 2014-09-08 |
| Neurobiological Effects of Light on MDD (NCT02940769) | University of Michigan | 2014-09-04 |
| Cognitive Training for Mood and Anxiety Disorders (NCT02256566) | Icahn School of Medicine at Mount Sinai | 2014-09-01 |
| Ketamine in Adolescents With Treatment-Resistant Depression (NCT02078817) | University of Minnesota | 2014-09-01 |
| Clinical Effect of dTMS in Major Depressive Disorder (NCT03265340) | Section for Affective Disorders; Northern Stockholm Psychiatry | 2014-09-01 |
| Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations (NCT04296604) | Massachusetts General Hospital | 2014-09-01 |
| Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans (NCT01851967) | Massachusetts General Hospital | 2014-09-01 |
| Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy (NCT02238730) | Kaiser Permanente | 2014-09-01 |
| Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine (NCT02176291) | Jordan F. Karp | 2014-08-01 |
| Kappa Opioid Receptor Imaging in Depression (KOR Depression) (NCT02236702) | NYU Langone Health | 2014-08-01 |
| Glutamate Probes in Adolescent Depression (NCT02307617) | Mayo Clinic | 2014-08-01 |
| Study to Treat Major Depressive Disorder (MDD) With a New Medication (NCT02149836) | Icahn School of Medicine at Mount Sinai | 2014-08-01 |
| Transdiagnostic iCBT for Depression and Anxiety (NCT02266693) | Centre for Addiction and Mental Health | 2014-08-01 |
| Enhancing Psychotherapy for Mood Disorders With Whole Body Hyperthermia (NCT02021149) | Charles (Chuck) Raison | 2014-07-01 |
| A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study (NCT02218008) | Alkermes, Inc. | 2014-07-01 |
| The Neurobiology of Approach Avoidance Training in Depression (NCT02330744) | University of California, San Diego | 2014-07-01 |
| Clinical Study of Generic and Brand Bupropion in Depression (NCT02209597) | Washington University School of Medicine | 2014-06-25 |
| Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression (NCT01973478) | Rennes University Hospital | 2014-06-03 |
| Chronotherapy Randomized Controlled Trial (NCT02176824) | Medical University of South Carolina | 2014-06-01 |
| Biomarkers of Fast Acting Therapies in Major Depression (NCT02165449) | University of California, Los Angeles | 2014-06-01 |
| Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression (NCT02176408) | Boston University Charles River Campus | 2014-06-01 |
| Noradrenergic Activity, Cognition and Major Depressive Disorder (NCT02470026) | Charite University, Berlin, Germany | 2014-06-01 |
| Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer (NCT02153281) | Centre for Addiction and Mental Health | 2014-06-01 |
| A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide (NCT02133001) | Janssen Research & Development, LLC | 2014-05-23 |
| A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study (NCT02158533) | Alkermes, Inc. | 2014-05-01 |
| Automatic Self Transcending Meditation Versus Treatment as Usual (NCT02149810) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2014-05-01 |
| Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant Depression (NCT02141776) | University of Florida | 2014-05-01 |
| A Long-Term Safety Study of ALKS 5461 (NCT02141399) | Alkermes, Inc. | 2014-05-01 |
| A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study (NCT02158546) | Alkermes, Inc. | 2014-05-01 |
| Pilot Study Assessing Computerized Cognitive Behavioral Therapy for Depression (NCT01990053) | Ohio State University | 2014-04-14 |
| Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases (NCT02079610) | Laureate Institute for Brain Research, Inc. | 2014-04-01 |
| Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients (NCT04181567) | Kaohsiung Kai-Suan Psychiatric Hospital | 2014-03-03 |
| Mobile Apps for the Treatment of Depression (NCT02024620) | Central Arkansas Veterans Healthcare System | 2014-03-01 |
| Pilot Study Comparing 10hz vs Theta Burst Stimulation (NCT02800226) | University of British Columbia | 2014-03-01 |
| Functional and Metabolic Changes in the Course of Antidepressive Treatment (NCT02099630) | Charite University, Berlin, Germany | 2014-03-01 |
| Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder (NCT02067793) | Naurex, Inc, an affiliate of Allergan plc | 2014-03-01 |
| Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCT (NCT02120729) | Hartford Hospital | 2014-03-01 |
| Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults (NCT01973283) | New York State Psychiatric Institute | 2014-02-19 |
| Mechanisms of Antidepressant Non-Response in Late-Life Depression (NCT01931202) | New York State Psychiatric Institute | 2014-02-19 |
| Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN) (NCT02051413) | Institut National de la Santé Et de la Recherche Médicale, France | 2014-02-18 |
| A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD) (NCT02085135) | Alkermes, Inc. | 2014-02-01 |
| Can Magnetic Brain Stimulation Help Prevent Relapse in Depression? (NCT02029963) | University of Manitoba | 2014-02-01 |
| Safety, Tolerability and Pharmacokinetics Study of LY03005 (NCT02055300) | Luye Pharma Group Ltd. | 2014-02-01 |
| A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder (NCT01957410) | Janssen Research & Development, LLC | 2014-02-01 |
| Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder (NCT02046564) | Otsuka Pharmaceutical Co., Ltd. | 2014-02-01 |
| Imaging Dopamine Release in Depression (NCT02033369) | New York State Psychiatric Institute | 2014-02-01 |
| Impact of an Eight Week Exercise Intervention in Treating Major Depressive Disorder (NCT03191994) | University of Ontario Institute of Technology | 2014-01-02 |